指南与共识瓣膜外科

2017年重度主动脉瓣狭窄患者治疗的适用标准:ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS联合报告

ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for the treatment of patients with severe aortic stenosis.
指南 / 共识 · Eur J Cardiothorac Surg · 2018-01-01

美国心脏病学会联合多家学会制定并评估重度主动脉瓣狭窄(AS)治疗的适用标准(AUC),基于指南、临床试验数据和专家意见构建95个临床场景及最多6种治疗选项,由独立评分小组按1-9分评分并分为「罕见适用」「可能适用」「适用」三类,旨在指导临床决策并减少不恰当干预。

要点

  • 本AUC针对重度AS的治疗选项,包括外科主动脉瓣置换和经导管主动脉瓣置换。
  • 基于症状和临床表现识别95个临床场景,每个场景最多6种治疗选项。
  • 评分1-3为「罕见适用」,4-6为「可能适用」,7-9为「适用」。

核心结论

  • 本AUC旨在通过识别基于各种临床场景的合理治疗和干预选项,为临床医生治疗重度AS患者提供指导。
  • 本AUC文件还可作为教育和质量改进工具,以识别治疗模式并减少临床实践中罕见适用的干预。

研究设计与样本

  • 美国心脏病学会与多家学会合作制定并评估重度AS治疗的适用标准(AUC)。
  • 写作组基于患者症状和临床表现识别95个临床场景,每个场景最多6种潜在治疗选项。
  • 独立的评分小组对每个适应证进行1-9分评分。

主要发现

  • 评分小组在考虑症状状态、左心室功能、外科风险和合并冠状动脉或其他瓣膜疾病等因素后,确定对于有症状的中危或高危外科风险AS患者,多数情况下外科主动脉瓣置换或经导管主动脉瓣置换是适用的。
  • 临床实践中常出现外科主动脉瓣置换或经导管主动脉瓣置换适应证不明确的情况,包括一种瓣膜置换形式看似合理而另一种不太合理的情形,以及其他两种干预均不适合的情形。

关键数值与推荐

  • 评分1-3分类为「罕见适用」,4-6为「可能适用」,7-9为「适用」。
  • 95个临床场景基于患者症状和临床表现,每个场景最多6种潜在治疗选项。
  • 主要参考2014 AHA/ACC瓣膜性心脏病管理指南及其2017重点更新。

临床怎么用

  • 本AUC为临床医生治疗重度AS患者提供指导,基于多种临床场景识别合理的治疗和干预选项。
  • 本AUC可作为教育和质量改进工具,识别治疗模式并减少罕见适用的干预。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The American College of Cardiology collaborated with the American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons to develop and evaluate Appropriate Use Criteria (AUC) for the treatment of patients with severe aortic stenosis (AS). This is the first AUC to address the topic of AS and its treatment options, including surgical aortic valve replacement and transcatheter aortic valve replacement. A number of common patient scenarios experienced in daily practice were developed along with assumptions and definitions for those scenarios, which were all created using guidelines, clinical trial data and expert opinion in the field of AS. The '2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines' [1] and its 2017 focused update paper [2] were used as the primary guiding references in developing these indications. The Writing Group identified 95 clinical scenarios based on patient symptoms and clinical presentation, and up to 6 potential treatment options for those patients. A separate, independent Rating Panel was asked to score each indication from 1 to 9, with 1-3 categorized as 'Rarely Appropriate', 4-6 as 'May Be Appropriate' and 7-9 as 'Appropriate'. After considering factors such as symptom status, left ventricular function, surgical risk, and the presence of concomitant coronary or other valve disease, the Rating Panel determined that either surgical aortic valve replacement or transcatheter aortic valve replacement is appropriate in most patients with symptomatic AS at intermediate or high surgical risk; however, situations commonly arise in clinical practice in which the indications for surgical aortic valve replacement or transcatheter aortic valve replacement are less clear, including situations in which one form of valve replacement would appear reasonable when the other is less so, as do other circumstances in which neither intervention is the suitable treatment option. The purpose of this AUC is to provide guidance to clinicians in the care of patients with severe AS by identifying the reasonable treatment and intervention options available based on the myriad clinical scenarios with which patients present. This AUC document also serves as an educational and quality improvement tool to identify patterns of care and reduce the number of rarely appropriate interventions in clinical practice.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Bonow RO, Brown AS, Gillam LD, et al. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for the treatment of patients with severe aortic stenosis. Eur J Cardiothorac Surg. 2018. PMID: 31089712. doi:10.1093/ejcts/ezx389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。